Although IDH-mutant diffuse gliomas have a relatively better prognosis, compared to high-grade astrocytomas/glioblastomas, they progressively transform to a more malignant phenotype. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).